Cardlytics (CDLX) Projected to Post Earnings on Wednesday

Cardlytics (NASDAQ:CDLX - Get Free Report) is anticipated to announce its Q1 2025 earnings results after the market closes on Wednesday, May 7th. Analysts expect Cardlytics to post earnings of ($0.27) per share and revenue of $58.07 million for the quarter.

Cardlytics Stock Performance

Shares of Cardlytics stock opened at $1.36 on Wednesday. The stock has a market capitalization of $70.70 million, a price-to-earnings ratio of -0.22 and a beta of 1.39. The firm's fifty day simple moving average is $1.93 and its 200-day simple moving average is $3.08. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. Cardlytics has a 12 month low of $1.22 and a 12 month high of $15.89.

Insider Buying and Selling at Cardlytics

In related news, CEO Amit Gupta sold 46,857 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $159,313.80. Following the transaction, the chief executive officer now directly owns 418,637 shares of the company's stock, valued at approximately $1,423,365.80. The trade was a 10.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Alexis Desieno sold 24,778 shares of the firm's stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total value of $84,245.20. Following the sale, the chief financial officer now directly owns 140,948 shares of the company's stock, valued at $479,223.20. This trade represents a 14.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 75,315 shares of company stock valued at $254,789. 4.40% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Evercore ISI dropped their price objective on shares of Cardlytics from $4.00 to $3.00 and set an "in-line" rating on the stock in a research note on Thursday, March 13th. Needham & Company LLC reissued a "hold" rating on shares of Cardlytics in a research note on Thursday, March 13th. Finally, Lake Street Capital dropped their price objective on Cardlytics from $5.00 to $3.00 and set a "hold" rating for the company in a report on Thursday, March 13th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $6.42.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.